• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜癌中的体细胞和种系突变。

Somatic and germline mutations in endometrial cancer.

机构信息

Department of Obstetrics and Gynecology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.

Department of Obstetrics and Gynecology, Alessandrescu-Rusescu National Institute of Mother and Child Health, Bucharest, Romania.

出版信息

J Med Life. 2024 Jun;17(6):564-573. doi: 10.25122/jml-2024-0313.

DOI:10.25122/jml-2024-0313
PMID:39296440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11407495/
Abstract

Endometrial cancer is a complex disease influenced by both somatic and germline mutations. While individual mutations in genes such as , and members of the DNA mismatch repair (MMR) system have been extensively studied, comprehensive analyses comparing somatic and germline mutations within the same cohort are limited. This study compares these mutations using whole exome sequencing (WES) data from tumor and blood samples in patients with endometrial cancer. Thirteen female patients with histologically confirmed endometrial cancer were selected. Tumor tissues and matched blood samples were collected and subjected to WES at the CeGaT laboratory, followed by bioinformatics analysis and annotation using the Geneyx platform. WES revealed significant somatic and germline DNA mutations, with key pathogenic variants identified in genes such as , and . Comparative analysis showed distinct and overlapping mutation profiles, highlighting the importance of integrating somatic and germline data in endometrial cancer research.

摘要

子宫内膜癌是一种受体细胞和种系突变影响的复杂疾病。虽然已经广泛研究了 等基因和 DNA 错配修复 (MMR) 系统成员中的个体突变,但在同一队列中比较体细胞和种系突变的综合分析仍然有限。本研究使用子宫内膜癌患者的肿瘤和血液样本的全外显子组测序 (WES) 数据比较了这些突变。选择了 13 名经组织学证实患有子宫内膜癌的女性患者。收集肿瘤组织和匹配的血液样本,并在 CeGaT 实验室进行 WES,然后使用 Geneyx 平台进行生物信息学分析和注释。WES 揭示了显著的体细胞和种系 DNA 突变,在 等基因中发现了关键的致病性变异。比较分析显示了不同但重叠的突变谱,突出了整合体细胞和种系数据在子宫内膜癌研究中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7b/11407495/6e9196e74066/JMedLife-17-564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7b/11407495/2f3a9e1a6848/JMedLife-17-564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7b/11407495/6e9196e74066/JMedLife-17-564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7b/11407495/2f3a9e1a6848/JMedLife-17-564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e7b/11407495/6e9196e74066/JMedLife-17-564-g002.jpg

相似文献

1
Somatic and germline mutations in endometrial cancer.子宫内膜癌中的体细胞和种系突变。
J Med Life. 2024 Jun;17(6):564-573. doi: 10.25122/jml-2024-0313.
2
Lynch Syndrome-associated Genomic Variants.林奇综合征相关的基因组变异。
J Gastrointestin Liver Dis. 2024 Sep 29;33(3):339-347. doi: 10.15403/jgld-5856.
3
Frequent PIK3CA Mutations in Colorectal and Endometrial Tumors With 2 or More Somatic Mutations in Mismatch Repair Genes.错配修复基因存在2个或更多体细胞突变的结直肠癌和子宫内膜肿瘤中频繁出现的PIK3CA突变
Gastroenterology. 2016 Sep;151(3):440-447.e1. doi: 10.1053/j.gastro.2016.06.004. Epub 2016 Jun 11.
4
Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations.错配修复缺陷的结肠癌和子宫内膜癌可能源于体细胞突变,而非种系突变。
Gastroenterology. 2014 Dec;147(6):1308-1316.e1. doi: 10.1053/j.gastro.2014.08.041. Epub 2014 Sep 3.
5
Double somatic mismatch repair gene pathogenic variants as common as Lynch syndrome among endometrial cancer patients.子宫内膜癌患者中双体种系错配修复基因突变与林奇综合征一样常见。
Gynecol Oncol. 2021 Jan;160(1):161-168. doi: 10.1016/j.ygyno.2020.10.012. Epub 2020 Oct 21.
6
Microsatellite Instability-High Endometrial Cancers with MLH1 Promoter Hypermethylation Have Distinct Molecular and Clinical Profiles.高度微卫星不稳定型子宫内膜癌伴 MLH1 启动子甲基化具有独特的分子和临床特征。
Clin Cancer Res. 2022 Oct 3;28(19):4302-4311. doi: 10.1158/1078-0432.CCR-22-0713.
7
Rare germline mutation and MSH2-&MSH6 + expression in a double primary carcinoma of colorectal carcinoma and endometrial carcinoma: a case report.罕见的种系突变和 MSH2-MSH6 表达在结直肠癌和子宫内膜癌的双原发癌中:一例报告。
Diagn Pathol. 2024 Jan 31;19(1):25. doi: 10.1186/s13000-024-01447-8.
8
Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.对于年龄小于 60 岁的子宫内膜癌患者,进行肿瘤错配修复免疫组化和 MLH1 甲基化 DNA 检测,可以优化人群级别的种系错配修复基因突变检测的分诊。
J Clin Oncol. 2014 Jan 10;32(2):90-100. doi: 10.1200/JCO.2013.51.2129. Epub 2013 Dec 9.
9
MLH1/PMS2-deficient Endometrial Carcinomas in a Universally Screened Population: MLH1 Hypermethylation and Germline Mutation Status.普遍筛查人群中 MLH1/PMS2 缺陷型子宫内膜癌:MLH1 高甲基化和种系突变状态。
Int J Gynecol Pathol. 2022 Jan 1;41(1):1-11. doi: 10.1097/PGP.0000000000000767.
10
Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D.采用 PROMISE 分类和额外的 MMR-D 基因分析对 108 例子宫内膜癌患者进行分析。
Gynecol Oncol. 2020 Apr;157(1):245-251. doi: 10.1016/j.ygyno.2020.01.019. Epub 2020 Jan 21.

引用本文的文献

1
Investigating the genetic landscape of cancer in Jordan: a step toward personalized care.探索约旦癌症的基因图谱:迈向个性化医疗的一步。
Eur J Med Res. 2025 Jul 2;30(1):544. doi: 10.1186/s40001-025-02799-7.

本文引用的文献

1
Recent Advances in Endometrial Cancer Prevention, Early Diagnosis and Treatment.子宫内膜癌预防、早期诊断与治疗的最新进展
Cancers (Basel). 2024 Mar 1;16(5):1028. doi: 10.3390/cancers16051028.
2
Diagnostic Potential of Endometrial Cancer DNA from Pipelle, Pap-Brush, and Swab Sampling.经皮普elle、巴氏刷和拭子采样获取的子宫内膜癌DNA的诊断潜力
Cancers (Basel). 2023 Jul 6;15(13):3522. doi: 10.3390/cancers15133522.
3
promoter methylation and expression in endometrial cancer tissues.子宫内膜癌组织中的启动子甲基化与表达
Epigenomics. 2023 Apr;15(8):507-516. doi: 10.2217/epi-2023-0099. Epub 2023 Jun 21.
4
PTEN mutations as predictive marker for the high-grade endometrial cancer development in slovak women.PTEN 突变作为斯洛伐克女性高级别子宫内膜癌发展的预测标志物。
Physiol Res. 2022 Dec 27;71(Suppl 1):S125-S135. doi: 10.33549/physiolres.935030.
5
KRAS-independent feedback activation of wild-type RAS constrains KRAS inhibitor efficacy.KRAS 非依赖性反馈激活野生型 RAS 会限制 KRAS 抑制剂的疗效。
Cell Rep. 2022 Jun 21;39(12):110993. doi: 10.1016/j.celrep.2022.110993.
6
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.帕博利珠单抗治疗微卫星高度不稳定型晚期子宫内膜癌患者:KEYNOTE-158 研究结果。
J Clin Oncol. 2022 Mar 1;40(7):752-761. doi: 10.1200/JCO.21.01874. Epub 2022 Jan 6.
7
Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives.阿培利司在治疗PIK3CA突变型乳腺癌中的作用:患者选择及临床前景
Ther Clin Risk Manag. 2021 Mar 5;17:193-207. doi: 10.2147/TCRM.S251668. eCollection 2021.
8
Germline Testing in Breast Cancers: Why, When and How?乳腺癌的胚系检测:为何、何时以及如何进行?
Cancers (Basel). 2020 Dec 14;12(12):3762. doi: 10.3390/cancers12123762.
9
Endometrial Cancers in or Germline Mutation Carriers: Assessment of Homologous Recombination DNA Repair Defects.存在胚系突变的子宫内膜癌患者:同源重组DNA修复缺陷的评估
JCO Precis Oncol. 2019 Aug 29;3. doi: 10.1200/PO.19.00103. eCollection 2019.
10
Cancer statistics, 2020.癌症统计数据,2020 年。
CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8.